뒤로뒤로EBIT 혹은 LSL PHARMA GROUP INC.
연간 데이터
−4.50 M
−3.00 M
−1.50 M
0.00
1.50 M
순마진
244.85 K
+4.36 M
—
2023
−4.12 M
−4.05 M
−5.71 K%
2022
−70.85 K
+16.67 K
+19.05%
2021
−87.52 K
−68.41 K
−357.98%
2020
−19.11 K
+25.17 K
+56.84%
분기 데이터
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−3.00 M
−2.00 M
−1.00 M
0.00
1.00 M
Q3 '24
85.00 K
+227.00 K
—
Q2 '24
−142.00 K
−321.00 K
−179.33%
Q1 '24
179.00 K
+56.15 K
+45.71%
Q4 '23
122.85 K
+458.80 K
—
Q3 '23
−335.95 K
+2.38 M
+87.61%
Q2 '23
−2.71 M
−1.52 M
−127.69%
Q1 '23
−1.19 M
−1.14 M
−2.21 K%
Q4 '22
−51.54 K
−45.66 K
−776.53%